References

  1. Allampallam K, Chakraborty J, Robinson J. Effect of ascorbic acid and growth factors on collagen metabolism of flexor retinaculum cells from individuals with and without carpal tunnel syndrome. J Occup Environ Med 42(3):251-9, 2000.

  2. Awad H A, Butler D L, Boivin G P, Smith F N, Malaviya P, Huibrejtse B. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 5(3):267-77, 1997.

  3. Butler D L, Awad H A. Perspectives on cell and collagen composites for tendon repair. Clin Orthop (367 suppl):S324-32, 1999.

  4. Astrom M, Rausing A. Chronic Achilles tendinopathy. A survey of surgical and histopathological findings. Clin Orthop Jul;(316):151-64, 1995.

  5. Cooper B, Oberdorfer ML, Rumpf D, Malakhova O E, Rudman R A, Mariotti A. Trauma modifies strength and composition of retrodiscal tissues of goat temporomandibular joint. Oral Diseases 5:329-336, 1999.

  6. Gage J P, Shaw R H, Malone F B. Collagen type in dysfunctional temporomandibular joint disks. J Prosthet Dent 74(5):517-520, 1995.

  7. Leadbetter W B, Cell matrix response in tendon injury. Clinics in Sports Medicine Vol II Num 3:533-577, 1992.

  8. Liu S H, Yang R S, Al-Shaikh R, Lane J M. Collagen in Tendon, Ligament, and Bone Healing. Clin Orth and Related Res Num 318:265-278, 1995.

  9. Maffulli N, Ewen SWB, Waterston SW, et al. Tenocytes from ruptured and tendinopathic Achilles tendons produce greater quantities of Type III collagen than tenocytes from normal Achilles tendons. Am J Sports Med 28(4):499-505, 2000.

  10. Mann V, Hobson E E, Li B, Stewart T L, Grant S F, Robins S P, Aspden R M, Ralston S H. A Col1A1 Sp1 binding site polymorphism predisposes to osteoporitic fracture by affecting bone density and quality. J Clin Invest 107(7):899-907, 2001.

  11. Mariotti A, Rumpf D, Malakhova O, Cooper B. Gender-specific differences in temporomandibular retrodiscal tissue in the goat. Eur J Oral Sci 108(5): 461-3, 2000.

  12. McGuigan F E, Armbrecht G, Smith R, Felsenberg D, Reid D M, Ralston S H. Prediction of osteoporotic fractures by bone densitometry and COL genotyping: a prospective population-based study in men and women. Osteoporosis Int 12(2):91-6, 2001.

  13. Riley G P, Harrnil R L, Constant C R, Chard M D, Causton T E, Hazleman B L. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 53(6):359-66, 1994.

  14. Westling L Temporomandibular joint dysfunction and systemic joint laxity. Swed Dent J Suppl 81:1-79, 1992.

  15. Young R G, Butler D L, Weber W, Caplan A I, Gordon S L, Fink D J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16(4):406-13, 1998.

  16. Ireland D, Harrall R, Curry V, Holloway G, Hackney R, Hazleman B, Riley GP. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol June;20(3):159-69, 2001.

  17. Riley GP, Cox M, Harrall RL, Clements S, Hazleman BL. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg June;26(3):224-8, 2001.

  18. Khan K M, Cook J L, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med June;27(6):393-408, 1999.

  19. Lee K, Majumdar MK, Buyaner D, Hendricks J K, Pittenger M F, Mosca J D. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther Jun;3(6):857-66, 2001.

  20. Goomer R S, Maris T M, Gelberman R, Boyer M, Silva M, Amiel D. Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin Orthop Oct;(379 Suppl):S189-200, 2000.

  21. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 78(6):303-11, 2000.

  22. Woo S L, Hildebrand K, Watanabe N, Fenwick J A, Papageorgiou C D, Wang J H. Tissue engineering of ligament and tendon healing. Clin Orthop Oct;(367 Suppl):S312-23, 1999.

  23. Lou J. In vivo gene transfer into tendon by recombinant adenovirus. Clin Orthop Oct;(379 Suppl):S252-55, 2000.

  24. Nakamura N, Hart D A, Boorman R S, Kaneda Y, Shrive N G, Marchuk L L, Shino K, Ochi T, Frank C B. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen figrillogenesis in vivo. J Orthop Res Jul;18(4):517-23, 2000.

  25. Forslund C, Aspenberg P. Tendon healing stimulated by injected CDMP-2. Med Sci Sports Exerc May;33(5):685-87, 2001.

  26. Chang J, Thunder R, Most D, Longaker M T, Lineaweaver W C. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg Jan;105(1):148-55, 2000.

  27. Chang J, Most D, Stelnicki E, Siebert J W, Longaker M T, Hui K, Lineweaver W C. Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: evidence for dual mechanisms of repair. Plast Reconstr Surg Sep;100(4):937-44, 1997.

  28. Murrell G A, Szabo C, Hannafin J A, Jang D, Dolan M M, Deng X H, Murrell D F, Warren R F. Modulation of tendon healing by nitric oxide. Inflamm Res Jan;46(1):19-27, 1997.

  29. Lin J H, Wang M X, Wei A, Zhu W, Diwan A D, Murrell G A. Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon. J Orthop Res Jan;19(1):136-42, 2001.

  30. Lin J, Wang M X, Wei A, Zhu W, Murrell G A. The cell specific temporal expression of nitric oxide synthase isoforms during achilles tendon healing. Inflamm Res Oct;50(10):515-22, 2001.

  31. Murphy D J; Nixon A J. Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocyte activity in equine flexor tendons. Am J Vet Res Jan;58(1):103-9, 1997.

  32. Conti N A, Dahners L E. The effect of exogenous growth factors on the healing of ligaments. Trans Orthop Res Soc 18:60, 1993.

  33. Letson A K, Dahners L E. The effect of combinations of growth factors on ligament healing. Clin Orthop 308;207-212, 1994.

  34. Kurtz C A, Loebig T G, Anderson D D, DeMeo P J, Campbell P G. Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med May-Jun;27(3):363-69, 1999.

  35. Abrahamsson S O. Similar effects of recombinant human insulin-like growth factor I and II on cellular activities in flexor tendons of young rabbits: experimental studies in vitro. J Orthop Res Mar;15(2):256-62, 1997.

  36. Aspenberg P, Forslund C. Enhanced tendon healing with GDF 5 and 6. Acta Orthop Scand Feb;70(1):51-54, 1999.

  37. Clark R T, Johnson T L, Schalet B J, Davis L, Gaschen V, Hunziker E B, Oldberg A, Mikic B. GDF-5 deficiency in mice leads to disruption of tail tendon form and function. Connect Tissue Res 42(3):175-86, 2001.

  38. Lou J, Tu Y, Burns M, Silva M J, Manske P. BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res Nov;19(6):1199-202, 2001.

  39. Hart D A, Nakamura N, Marchuk L, Hiraoka H, Boorman R, Kaneda Y, Shrive N G, Frank C B. Complexity of determining cause and effect in vitro after antisense gene therapy. Clin Orthop Oct;(379 Suppl):S242-52, 2000.

  40. Riley G P, Harrall R L, Constant C R, Chard M D, Cawston T E, Hazleman B. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis Jun;53(6):367-76, 1994.

  41. Khan KM, Cook JL, Taunton JE, et al. Overuse tendinosis, not tendinitis: a new paradigm for a difficult clinical problem. Phys Sportsmed;28(5):38-48, 2000.

  42. Khan KM, Cook JL, Maffulli N, Kannus P. Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med;34(2):81-84, 2000.

  43. Martinek V, Fu F, Huard J. Gene Therapy and Tissue Engineering in Sports Medicine. Phys Sportsmed; 28(2), 2000.

  44. Khan KM, Cook JL, Kannus P, Maffulli N, Bonar SF. Time to abandon the "tendinitis" myth. BMJ;324:626-527, 2002.

  45. Maffulli N, Khan KM, Puddu G. Overuse tendon conditions. Time to change a confusing terminology. Arthroscopy;14:840-843, 1998.

  46. Gerr F, Marcus M, Ensor C, Kleinbaum D, Cohen S, Edwards A, Gentry E, Ortiz DJ, Monteilh C. A prospective study of computer users: I. Study design and incidence of musculoskeletal symptoms and disorders. Am J Ind Med;Apr:41(4):221-35, 2002.

  47. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med;Jun:7(6):259-64, 2001.

  48. Craig J. Davidson et. al., "Rat tendon morphologic and functional changes resulting from soft tissue mobilization", Medicine & Science in Sports & Exercise, Mar. 1997, Vol. 29, No. 3, pp. 313-319.

  49. Gale M. Gehlsen, "Fibroblast responses to variation in soft tissue mobilization pressure", Medicine & Science in Sports & Exercise, Apr. 1999, Vol. 31, No. 4, pp. 531-535.

  50. Alfredson, H., Pietila, T., Jonsson, P., Lorentzon, R. Heavy-Load Eccentric Calf Muscle Training For the Treatment of Chronic Achilles Tendinosis. AJSM. Vol. 26 (3), 1998. pp.360-366.

  51. Shalabi, A., Kristofferson-Wilberg, M., Svensson, L., Aspelin, P., Movin, T. Eccentric Training of the Gastrocnemius-Soleus Complex in Chronic Achilles Tendiopathy Results in Decreased Tendon Volume and Intratendinous Signal as Evaluated by MRI. AJSM, Vol. 32 No. X, 2004.

  52. Alfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998;26:360-366.

  53. Cannell LJ, Taunton JE, Clement DB, Smith C, Khan KM. A randomised clinical trial of the efficacy of drop squats or leg extension/leg curl exercises to treat clinically diagnosed jumper’s knee in athletes: pilot study. Br J Sports Med. 2001;35:60-64.

  54. Jensen K, Di Fabio RP. Evaluation of eccentric exercise in treatment of patellar tendinitis. Phys Ther. 1989;69:211-216.

  55. Connell D, Datir A, Alyas F, Curtis M. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med. 2009 Apr;43(4):293-8.

  56. Clarke Andrew W, Alyas F, Morris T, Robertson C, Bell J , Connell D. Skin-Derived Tenocyte-like Cells for the Treatment of Patellar Tendinopathy. Am J Sports Med March 2011 39 614-623.

  57. Pascual-Garrido C, Rolon A, Makino A. Treatment of Chronic Patellar Tendinopathy with Autologous Bone Marrow Stem Cells: A Five Year Follow Up. Stem Cells International, Vol 2012, Article ID 953510, 5 pages.

  58. Murrell GA. (2007). "Using nitric oxide to treat tendinopathy". Br J Sports Med 41 (4): 227–31.

  59. Allan Wang, William Breidahl, Katherine E. Mackie, Zhen Lin, An Qin, Jimin Chen, Ming H. Zheng. Autologous Tenocyte Injection for the Treatment of Severe, Chronic Resistant Lateral Epicondylitis, A Pilot Study. The American Journal of Sports Medicine December 2013 vol. 41 no. 12 2925-2932.

  60. Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med. 2003;31:915–920

  61. Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2004;86-A:916–922.

  62. Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical glyceryl trinitrate application in the treatment of chronic supraspinatus tendinopathy: a randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med. 2005;33:806–813.

  63. Paoloni JA, Murrell GA. Three-year followup study of topical glyceryl trinitrate treatment of chronic noninsertional Achilles tendinopathy. Foot Ankle Int. 2007;28:1064–1068.

  64. Andres BM, Murrell GA. Treatment of Tendinopathy: What Works, What Does Not, and What is on the Horizon. Clin Orthop Relat Res. Jul 2008; 466(7): 1539–1554.

  65. Kragsnaes MS, Fredberg U, Stribolt K, Kjaer SG, Bendix K, and Ellingsen T. Stereological Quantification of Immune-Competent Cells in Baseline Biopsy Specimens From Achilles Tendons; Results From Patients With Chronic Tendinopathy Followed for More Than 4 Years. AJSM Jul 31 2014 online.

  66. Rees JD, Stride M, Scott A. Tendons – time to revisit inflammation. BJSM March 2013 online.

  67. Alex Scott, Sean Docking, Bill Vicenzino, Håkan Alfredson, Johannes Zwerver, Kirsten Lundgreen, Oliver Finlay, Noel Pollock, Jill L Cook, Angela Fearon, Craig R Purdam, Alison Hoens, Jonathan D Rees, Thomas J Goetz, and Patrik Danielson. Sports and exercise-related tendinopathies: a review of selected topical issues by participants of the second International Scientific Tendinopathy Symposium (ISTS) Vancouver 2012. Br J Sports Med. Jun 2013; 47(9): 536–544. Online.

  68. Collins M, Raleigh SM. Genetic risk factors for musculoskeletal soft tissue injuries. Med Sport Sci. 2009;54:136-49. doi: 10.1159/000235701. Epub 2009 Aug 17. Online.

New Site Name:

We have changed the name of the site from tendinosis.org to tendonpain.org because the information here covers both tendinosis and tendinopathy.


Facebook Feed:

We post links to new research on our Facebook feed, so that is the best way to keep up with the latest news. Follow us on Facebook.


Forum:

Check out our Forum. If you want to join in the discussion, please register a new username and then send us an email and we will approve your membership. We have to activate your new membership by hand to prevent auto spammer activity on the board. Once activated, you can post with your new account.


Contact:

Email us at: info@tendonpain.org


Tendon Research News:

University of Glasgow: Scientific breakthrough unlocks potential novel tendon therapy
”Tendinopathy is essentially the result of an imbalance between collagen type-1 and type-3 and we have discovered the molecular cause. This breakthrough has allowed us to find a way to alter the levels of collagen type-3 in tendons, with the ultimate aim to get patients with tendon injuries better quicker."

Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study
“This study showed that significant improvement in healing outcomes could be achieved by the use of BMC (bone marrow concentrate) containing MSC (mesenchymal stem cells) as an adjunct therapy in standard of care rotator cuff repair. Furthermore, our study showed a substantial improvement in the level of tendon integrity present at the ten-year milestone between the MSC-treated group and the control patients.”

Treatment of Lateral Epicondylosis Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study
“This pilot study on the safety and efficacy of allo-MSC injection for treating chronic LE demonstrated that the intervention was safe and efficacious in improving pain, performance, and anatomical defects for more than a 52-week follow-up period. This is the first clinical study using allogeneic MSCs to treat chronic tendinopathy.”

Cell Therapy Ltd announces positive Phase II clinical trial results of Tendoncel ™, a first-in-class topical regenerative medicine for severe tendon injury
“Patients using the non-invasive Tendoncel ™ topical gel for 21 days experienced a clinically relevant and statistically significant improvement in their tendon injury. Reporting an average improvement of 70% on the DASH disability scale and 74% improvement on the PRTEE scale, Tendoncel’s results exceed those expected of injectable treatments and have the advantage of painless topical application.”

Mechanotherapy: how physical therapists’ prescription of exercise promotes tissue repair
“Mechanotransduction is the physiological process where cells sense and respond to mechanical loads. This paper reclaims the term “mechanotherapy” and presents the current scientific knowledge underpinning how load may be used therapeutically to stimulate tissue repair and remodelling in tendon, muscle, cartilage and bone.”